We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+3.12%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$4.52B
AUM Growth
-$85.5M
(-1.9%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
31.88%
Holding
897
New
120
Increased
212
Reduced
333
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$26.9M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$8.23M |
| 3 |
Gilead Sciences
GILD
|
+$7.91M |
| 4 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$7.7M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$7.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$20.5M |
| 2 |
NVIDIA
NVDA
|
+$15.2M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$14.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$14.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.36% |
| 2 | Financials | 7.83% |
| 3 | Healthcare | 7.13% |
| 4 | Communication Services | 6.57% |
| 5 | Consumer Discretionary | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Valley National Bancorp
VLY
$8.03B
| $166K | ﹤0.01% |
+14,200
| New | +$158K |
|
727
Cytek Biosciences
CTKB
$582M
| $148K | ﹤0.01% |
29,300
| – | – |
|
728
CorMedix
CRMD
$618M
| $142K | ﹤0.01% |
+12,200
| New | +$135K |
|
729
Fulcrum Therapeutics
FULC
$252M
| $133K | ﹤0.01% |
11,781
-15,100
| -56% | -$154K |
|
730
Erasca
ERAS
$6.79B
| $131K | ﹤0.01% |
+35,238
| New | +$99.1K |
|
731
Protara Therapeutics
TARA
$229M
| $130K | ﹤0.01% |
24,417
-12,252
| -33% | -$68.1K |
|
732
Uranium Energy
UEC
$4.77B
| $122K | ﹤0.01% |
10,416
-27,969
| -73% | -$367K |
|
733
Xeris Biopharma Holdings
XERS
$1.44B
| $120K | ﹤0.01% |
+15,300
| New | +$120K |
|
734
Nkarta
NKTX
$167M
| $117K | ﹤0.01% |
63,400
+33,800
| +114% | +$67.6K |
|
735
Zevra Therapeutics
ZVRA
$559M
| $116K | ﹤0.01% |
+12,900
| New | +$122K |
|
736
Bloomin' Brands
BLMN
$689M
| $114K | ﹤0.01% |
+18,500
| New | +$129K |
|
|
NAGE
737
Niagen Bioscience
NAGE
$254M
| $106K | ﹤0.01% |
+16,700
| New | +$116K |
|
|
NHS
738
Neuberger High Yield Strategies Fund Inc
NHS
$251M
| $80.6K | ﹤0.01% |
10,839
| – | – |
|
739
Actinium Pharmaceuticals
ATNM
$27.7M
| $78.7K | ﹤0.01% |
+57,867
| New | +$84.4K |
|
740
Ideal Power
IPWR
$65.9M
| $62.9K | ﹤0.01% |
20,365
-2,175
| -10% | -$9.58K |
|
741
Telos
TLS
$342M
| $62.7K | ﹤0.01% |
+12,300
| New | +$76.8K |
|
742
SurgePays
SURG
$6.02M
| $46.7K | ﹤0.01% |
27,975
-17,100
| -38% | -$38.1K |
|
743
Agilon Health
AGL
$1.73B
| $29K | ﹤0.01% |
1,686
| – | – |
|
744
PMV Pharmaceuticals
PMVP
$66.7M
| $21.3K | ﹤0.01% |
+17,069
| New | +$22.9K |
|
745
Advance Auto Parts
AAP
$3.28B
| – | – |
-10,788
| Closed | -$662K |
|
746
Enact Holdings
ACT
$6.51B
| – | – |
-11,188
| Closed | -$429K |
|
747
Addus HomeCare
ADUS
$2.14B
| – | – |
-2,100
| Closed | -$248K |
|
748
Aegon
AEG
$13.5B
| – | – |
-10,306
| Closed | -$82.3K |
|
749
American Electric Power
AEP
$73.6B
| – | – |
-7,981
| Closed | -$898K |
|
|
ALEX
750
DELISTED
Alexander & Baldwin
ALEX
| – | – |
-21,811
| Closed | -$397K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q4 2025 Portfolio in Review
As of Q4 2025, Bailard held 897 positions worth $4.52B, down 1.9% from $4.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bailard withdrew a net $178M in Q4 2025, closing 153 positions and reducing 333 holdings. Its most notable exit was Vanguard Small-Cap Growth ETF, an estimated $5.29M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bailard opened a new position in Vanguard Short-Term Inflation-Protected Securities Index Fund worth $26.6M.
- Bailard's largest Q4 2025 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 538,707 shares worth $26.6M.
- Bailard added most to iShares Short-Term National Muni Bond ETF in Q4 2025, an estimated $8.23M increase.
- Bailard's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $20.5M.
- Bailard fully exited Vanguard Small-Cap Growth ETF in Q4 2025, selling an estimated $5.29M.
- Bailard's ten largest holdings make up 32% of its $4.52B portfolio in Q4 2025.
- Bailard opened 120 new positions and closed 153 in Q4 2025.
- Bailard's portfolio value fell 1.9% quarter-over-quarter to $4.52B.
Based on Bailard's 13F filing for Q4 2025, filed 4 Feb 2026.